nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—ABCG2—gout	0.386	1	CbGaD
Nilotinib—UGT1A1—Naproxen—gout	0.0806	0.207	CbGbCtD
Nilotinib—UGT1A1—Indomethacin—gout	0.0532	0.137	CbGbCtD
Nilotinib—CYP2B6—Colchicine—gout	0.0236	0.0606	CbGbCtD
Nilotinib—CYP2C8—Naproxen—gout	0.0236	0.0606	CbGbCtD
Nilotinib—ABCG2—Hydrocortisone—gout	0.018	0.0463	CbGbCtD
Nilotinib—CYP2C8—Colchicine—gout	0.0179	0.0459	CbGbCtD
Nilotinib—CYP2C9—Naproxen—gout	0.0165	0.0423	CbGbCtD
Nilotinib—CYP2C8—Probenecid—gout	0.016	0.0411	CbGbCtD
Nilotinib—CYP2C9—Colchicine—gout	0.0125	0.032	CbGbCtD
Nilotinib—ABCB1—Colchicine—gout	0.0121	0.0311	CbGbCtD
Nilotinib—CYP2C9—Probenecid—gout	0.0112	0.0287	CbGbCtD
Nilotinib—CYP2C9—Indomethacin—gout	0.0109	0.0279	CbGbCtD
Nilotinib—ABCB1—Probenecid—gout	0.0108	0.0278	CbGbCtD
Nilotinib—ABCB1—Methylprednisolone—gout	0.0107	0.0274	CbGbCtD
Nilotinib—ABCB1—Indomethacin—gout	0.0106	0.0271	CbGbCtD
Nilotinib—CYP2C8—Hydrocortisone—gout	0.00961	0.0247	CbGbCtD
Nilotinib—CYP3A4—Colchicine—gout	0.00726	0.0186	CbGbCtD
Nilotinib—ABCB1—Prednisolone—gout	0.00686	0.0176	CbGbCtD
Nilotinib—ABCB1—Hydrocortisone—gout	0.00651	0.0167	CbGbCtD
Nilotinib—CYP3A4—Probenecid—gout	0.0065	0.0167	CbGbCtD
Nilotinib—ABCB1—Prednisone—gout	0.00648	0.0166	CbGbCtD
Nilotinib—CYP3A4—Methylprednisolone—gout	0.00641	0.0164	CbGbCtD
Nilotinib—CYP3A4—Prednisolone—gout	0.00411	0.0106	CbGbCtD
Nilotinib—CYP3A4—Hydrocortisone—gout	0.0039	0.01	CbGbCtD
Nilotinib—CYP3A4—Prednisone—gout	0.00388	0.00996	CbGbCtD
Nilotinib—Ponatinib—ABCG2—gout	0.00235	0.619	CrCbGaD
Nilotinib—Imatinib—ABCG2—gout	0.00145	0.381	CrCbGaD
Nilotinib—EPHB2—Diflorasone—Methylprednisolone—gout	0.000739	0.357	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Prednisone—gout	0.000674	0.326	CbGdCrCtD
Nilotinib—EPHB2—Diflorasone—Prednisolone—gout	0.000658	0.318	CbGdCrCtD
Nilotinib—CDC42BPB—tendon—gout	0.000391	0.0771	CbGeAlD
Nilotinib—FGR—Hemostasis—LRRC16A—gout	0.000385	0.0106	CbGpPWpGaD
Nilotinib—LYN—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000385	0.0106	CbGpPWpGaD
Nilotinib—ABL1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000383	0.0105	CbGpPWpGaD
Nilotinib—CA3—Metabolism—BCKDHA—gout	0.000359	0.00986	CbGpPWpGaD
Nilotinib—MAPK8—tendon—gout	0.000354	0.0697	CbGeAlD
Nilotinib—MAPK8—Apoptosis Modulation and Signaling—CASP1—gout	0.000342	0.0094	CbGpPWpGaD
Nilotinib—BLK—Apoptosis Modulation and Signaling—CASP1—gout	0.000342	0.0094	CbGpPWpGaD
Nilotinib—HCK—Signaling by Interleukins—CASP1—gout	0.000329	0.00905	CbGpPWpGaD
Nilotinib—MAP4K1—tendon—gout	0.000322	0.0633	CbGeAlD
Nilotinib—HCK—Signaling by Interleukins—IL1RN—gout	0.000319	0.00876	CbGpPWpGaD
Nilotinib—EPHA2—Direct p53 effectors—CASP1—gout	0.000319	0.00876	CbGpPWpGaD
Nilotinib—MAPK14—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.000314	0.00863	CbGpPWpGaD
Nilotinib—MAP4K1—MAPK Signaling Pathway—CASP1—gout	0.000301	0.00828	CbGpPWpGaD
Nilotinib—BRAF—tendon—gout	0.000294	0.0579	CbGeAlD
Nilotinib—CA3—Metabolism—HPRT1—gout	0.000292	0.00804	CbGpPWpGaD
Nilotinib—CA3—Metabolism—PRPS1—gout	0.000292	0.00804	CbGpPWpGaD
Nilotinib—CA3—Metabolism—PRPS2—gout	0.000292	0.00804	CbGpPWpGaD
Nilotinib—UGT1A1—NRF2 pathway—SLC2A9—gout	0.000286	0.00787	CbGpPWpGaD
Nilotinib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000277	0.00763	CbGpPWpGaD
Nilotinib—HCK—tendon—gout	0.000268	0.0528	CbGeAlD
Nilotinib—ABL2—tendon—gout	0.000267	0.0525	CbGeAlD
Nilotinib—EPHA4—tendon—gout	0.000244	0.048	CbGeAlD
Nilotinib—CA3—tendon—gout	0.000241	0.0474	CbGeAlD
Nilotinib—LYN—Hemostasis—LRRC16A—gout	0.000232	0.00637	CbGpPWpGaD
Nilotinib—CA14—Metabolism—BCKDHA—gout	0.000231	0.00636	CbGpPWpGaD
Nilotinib—ABL1—Hemostasis—LRRC16A—gout	0.000231	0.00634	CbGpPWpGaD
Nilotinib—CA9—tendon—gout	0.000231	0.0454	CbGeAlD
Nilotinib—CA6—Metabolism—BCKDHA—gout	0.000225	0.00619	CbGpPWpGaD
Nilotinib—MAPK14—tendon—gout	0.000225	0.0443	CbGeAlD
Nilotinib—FGR—tendon—gout	0.000224	0.0441	CbGeAlD
Nilotinib—MAPK14—Leptin signaling pathway—IL1RN—gout	0.00022	0.00604	CbGpPWpGaD
Nilotinib—MAPK14—Hemostasis—LRRC16A—gout	0.00022	0.00604	CbGpPWpGaD
Nilotinib—CA14—tendon—gout	0.000219	0.0431	CbGeAlD
Nilotinib—EPHB4—tendon—gout	0.000213	0.042	CbGeAlD
Nilotinib—CA7—Metabolism—BCKDHA—gout	0.00021	0.00578	CbGpPWpGaD
Nilotinib—MAPK8—MAPK Signaling Pathway—CASP1—gout	0.000209	0.00576	CbGpPWpGaD
Nilotinib—EPHA2—tendon—gout	0.000209	0.0412	CbGeAlD
Nilotinib—TEK—tendon—gout	0.000204	0.0402	CbGeAlD
Nilotinib—MAP2K5—MAPK Signaling Pathway—CASP1—gout	0.000199	0.00547	CbGpPWpGaD
Nilotinib—EPHB6—tendon—gout	0.000195	0.0384	CbGeAlD
Nilotinib—CA12—Metabolism—BCKDHA—gout	0.000195	0.00536	CbGpPWpGaD
Nilotinib—LCK—Hemostasis—LRRC16A—gout	0.00019	0.00522	CbGpPWpGaD
Nilotinib—CA14—Metabolism—PRPS1—gout	0.000188	0.00518	CbGpPWpGaD
Nilotinib—CA14—Metabolism—HPRT1—gout	0.000188	0.00518	CbGpPWpGaD
Nilotinib—CA14—Metabolism—PRPS2—gout	0.000188	0.00518	CbGpPWpGaD
Nilotinib—PDGFRA—tendon—gout	0.000185	0.0364	CbGeAlD
Nilotinib—CA6—Metabolism—PRPS1—gout	0.000184	0.00505	CbGpPWpGaD
Nilotinib—CA6—Metabolism—HPRT1—gout	0.000184	0.00505	CbGpPWpGaD
Nilotinib—CA6—Metabolism—PRPS2—gout	0.000184	0.00505	CbGpPWpGaD
Nilotinib—MAPK8—Glucocorticoid receptor regulatory network—POMC—gout	0.000182	0.00501	CbGpPWpGaD
Nilotinib—LYN—Signaling by Interleukins—CASP1—gout	0.000179	0.00492	CbGpPWpGaD
Nilotinib—HCK—Innate Immune System—NLRP3—gout	0.000176	0.00485	CbGpPWpGaD
Nilotinib—LYN—Signaling by Interleukins—IL1RN—gout	0.000173	0.00476	CbGpPWpGaD
Nilotinib—CA7—Metabolism—PRPS1—gout	0.000171	0.00471	CbGpPWpGaD
Nilotinib—CA7—Metabolism—PRPS2—gout	0.000171	0.00471	CbGpPWpGaD
Nilotinib—CA7—Metabolism—HPRT1—gout	0.000171	0.00471	CbGpPWpGaD
Nilotinib—MAP2K5—tendon—gout	0.000167	0.0328	CbGeAlD
Nilotinib—MAPK8—Corticotropin-releasing hormone—POMC—gout	0.000166	0.00456	CbGpPWpGaD
Nilotinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000165	0.00454	CbGpPWpGaD
Nilotinib—BRAF—MAPK Signaling Pathway—CASP1—gout	0.000165	0.00454	CbGpPWpGaD
Nilotinib—CSF1R—tendon—gout	0.000163	0.032	CbGeAlD
Nilotinib—MAPK8—Innate Immune System—NLRP3—gout	0.00016	0.00439	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—NLRP3—gout	0.000159	0.00438	CbGpPWpGaD
Nilotinib—CA12—Metabolism—PRPS2—gout	0.000159	0.00437	CbGpPWpGaD
Nilotinib—CA12—Metabolism—PRPS1—gout	0.000159	0.00437	CbGpPWpGaD
Nilotinib—CA12—Metabolism—HPRT1—gout	0.000159	0.00437	CbGpPWpGaD
Nilotinib—CA4—Metabolism—BCKDHA—gout	0.000155	0.00427	CbGpPWpGaD
Nilotinib—HCK—Cytokine Signaling in Immune system—CASP1—gout	0.000154	0.00422	CbGpPWpGaD
Nilotinib—CA2—Metabolism—BCKDHA—gout	0.000149	0.0041	CbGpPWpGaD
Nilotinib—HCK—Cytokine Signaling in Immune system—IL1RN—gout	0.000149	0.00409	CbGpPWpGaD
Nilotinib—LCK—Signaling by Interleukins—CASP1—gout	0.000147	0.00403	CbGpPWpGaD
Nilotinib—MAPK11—Glucocorticoid receptor regulatory network—POMC—gout	0.000145	0.00399	CbGpPWpGaD
Nilotinib—PDGFRB—tendon—gout	0.000144	0.0284	CbGeAlD
Nilotinib—HCK—Disease—PRPS2—gout	0.000143	0.00393	CbGpPWpGaD
Nilotinib—HCK—Disease—PRPS1—gout	0.000143	0.00393	CbGpPWpGaD
Nilotinib—CA1—Metabolism—BCKDHA—gout	0.000143	0.00393	CbGpPWpGaD
Nilotinib—LCK—Signaling by Interleukins—IL1RN—gout	0.000142	0.0039	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	0.000135	0.00372	CbGpPWpGaD
Nilotinib—BRAF—Corticotropin-releasing hormone—POMC—gout	0.000131	0.0036	CbGpPWpGaD
Nilotinib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.00013	0.00358	CbGpPWpGaD
Nilotinib—ABL1—tendon—gout	0.000129	0.0253	CbGeAlD
Nilotinib—PDGFRB—MAPK Signaling Pathway—CASP1—gout	0.000128	0.00353	CbGpPWpGaD
Nilotinib—MAPK11—Innate Immune System—NLRP3—gout	0.000127	0.0035	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PRPS1—gout	0.000127	0.00348	CbGpPWpGaD
Nilotinib—CA4—Metabolism—HPRT1—gout	0.000127	0.00348	CbGpPWpGaD
Nilotinib—CA4—Metabolism—PRPS2—gout	0.000127	0.00348	CbGpPWpGaD
Nilotinib—CA9—Metabolism—BCKDHA—gout	0.000126	0.00345	CbGpPWpGaD
Nilotinib—CA2—Metabolism—HPRT1—gout	0.000121	0.00334	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PRPS1—gout	0.000121	0.00334	CbGpPWpGaD
Nilotinib—CA2—Metabolism—PRPS2—gout	0.000121	0.00334	CbGpPWpGaD
Nilotinib—MAPK14—MAPK Signaling Pathway—CASP1—gout	0.000119	0.00327	CbGpPWpGaD
Nilotinib—CA1—Metabolism—HPRT1—gout	0.000116	0.0032	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PRPS2—gout	0.000116	0.0032	CbGpPWpGaD
Nilotinib—CA1—Metabolism—PRPS1—gout	0.000116	0.0032	CbGpPWpGaD
Nilotinib—KIT—Innate Immune System—NLRP3—gout	0.000115	0.00316	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	0.00011	0.00304	CbGpPWpGaD
Nilotinib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	0.00011	0.00304	CbGpPWpGaD
Nilotinib—PDGFRA—Innate Immune System—NLRP3—gout	0.000109	0.00299	CbGpPWpGaD
Nilotinib—CA3—Metabolism—ABCG2—gout	0.000108	0.00298	CbGpPWpGaD
Nilotinib—Gastrointestinal pain—Naproxen—gout	0.000107	0.000607	CcSEcCtD
Nilotinib—Myocardial infarction—Prednisolone—gout	0.000107	0.000606	CcSEcCtD
Nilotinib—Neuropathy peripheral—Prednisolone—gout	0.000107	0.000606	CcSEcCtD
Nilotinib—Infestation—Hydrocortisone—gout	0.000107	0.000604	CcSEcCtD
Nilotinib—Infestation NOS—Hydrocortisone—gout	0.000107	0.000604	CcSEcCtD
Nilotinib—Pruritus—Allopurinol—gout	0.000106	0.000602	CcSEcCtD
Nilotinib—Conjunctivitis—Prednisolone—gout	0.000106	0.000601	CcSEcCtD
Nilotinib—CA4—tendon—gout	0.000106	0.0208	CbGeAlD
Nilotinib—Cardiac failure—Prednisone—gout	0.000105	0.000598	CcSEcCtD
Nilotinib—Vomiting—Indomethacin—gout	0.000105	0.000596	CcSEcCtD
Nilotinib—Acute coronary syndrome—Hydrocortisone—gout	0.000105	0.000595	CcSEcCtD
Nilotinib—Lethargy—Prednisone—gout	0.000105	0.000595	CcSEcCtD
Nilotinib—Neuropathy peripheral—Hydrocortisone—gout	0.000104	0.000592	CcSEcCtD
Nilotinib—Myocardial infarction—Hydrocortisone—gout	0.000104	0.000592	CcSEcCtD
Nilotinib—Rash—Indomethacin—gout	0.000104	0.000591	CcSEcCtD
Nilotinib—Dermatitis—Indomethacin—gout	0.000104	0.000591	CcSEcCtD
Nilotinib—Urticaria—Naproxen—gout	0.000104	0.00059	CcSEcCtD
Nilotinib—Headache—Indomethacin—gout	0.000104	0.000587	CcSEcCtD
Nilotinib—Abdominal pain—Naproxen—gout	0.000104	0.000587	CcSEcCtD
Nilotinib—Body temperature increased—Naproxen—gout	0.000104	0.000587	CcSEcCtD
Nilotinib—MAPK14—Glucocorticoid receptor regulatory network—POMC—gout	0.000104	0.00285	CbGpPWpGaD
Nilotinib—Nausea—Colchicine—gout	0.000103	0.000586	CcSEcCtD
Nilotinib—Gastrointestinal haemorrhage—Prednisone—gout	0.000103	0.000583	CcSEcCtD
Nilotinib—Diarrhoea—Allopurinol—gout	0.000103	0.000582	CcSEcCtD
Nilotinib—HCK—Immune System—NLRP3—gout	0.000103	0.00282	CbGpPWpGaD
Nilotinib—BRAF—Disease—PRPS2—gout	0.000102	0.00281	CbGpPWpGaD
Nilotinib—BRAF—Disease—PRPS1—gout	0.000102	0.00281	CbGpPWpGaD
Nilotinib—CA9—Metabolism—HPRT1—gout	0.000102	0.00281	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PRPS1—gout	0.000102	0.00281	CbGpPWpGaD
Nilotinib—CA9—Metabolism—PRPS2—gout	0.000102	0.00281	CbGpPWpGaD
Nilotinib—Weight increased—Methylprednisolone—gout	0.000102	0.000579	CcSEcCtD
Nilotinib—Infestation NOS—Methylprednisolone—gout	0.0001	0.000567	CcSEcCtD
Nilotinib—Infestation—Methylprednisolone—gout	0.0001	0.000567	CcSEcCtD
Nilotinib—Bradycardia—Prednisolone—gout	9.98e-05	0.000565	CcSEcCtD
Nilotinib—Face oedema—Prednisone—gout	9.94e-05	0.000563	CcSEcCtD
Nilotinib—Dizziness—Allopurinol—gout	9.93e-05	0.000563	CcSEcCtD
Nilotinib—Acute coronary syndrome—Methylprednisolone—gout	9.87e-05	0.000559	CcSEcCtD
Nilotinib—Haemoglobin—Prednisolone—gout	9.85e-05	0.000558	CcSEcCtD
Nilotinib—Nausea—Indomethacin—gout	9.83e-05	0.000557	CcSEcCtD
Nilotinib—Neuropathy peripheral—Methylprednisolone—gout	9.82e-05	0.000556	CcSEcCtD
Nilotinib—Myocardial infarction—Methylprednisolone—gout	9.82e-05	0.000556	CcSEcCtD
Nilotinib—Haemorrhage—Prednisolone—gout	9.8e-05	0.000555	CcSEcCtD
Nilotinib—PDGFRB—Innate Immune System—NLRP3—gout	9.79e-05	0.00269	CbGpPWpGaD
Nilotinib—Bradycardia—Hydrocortisone—gout	9.74e-05	0.000552	CcSEcCtD
Nilotinib—Hypersensitivity—Naproxen—gout	9.66e-05	0.000547	CcSEcCtD
Nilotinib—Haemoglobin—Hydrocortisone—gout	9.62e-05	0.000545	CcSEcCtD
Nilotinib—LYN—Innate Immune System—NLRP3—gout	9.58e-05	0.00263	CbGpPWpGaD
Nilotinib—Haemorrhage—Hydrocortisone—gout	9.57e-05	0.000542	CcSEcCtD
Nilotinib—Vomiting—Allopurinol—gout	9.55e-05	0.000541	CcSEcCtD
Nilotinib—ABL1—Innate Immune System—NLRP3—gout	9.54e-05	0.00262	CbGpPWpGaD
Nilotinib—Rash—Allopurinol—gout	9.47e-05	0.000536	CcSEcCtD
Nilotinib—Dermatitis—Allopurinol—gout	9.46e-05	0.000536	CcSEcCtD
Nilotinib—Visual impairment—Prednisolone—gout	9.44e-05	0.000535	CcSEcCtD
Nilotinib—MAPK14—Corticotropin-releasing hormone—POMC—gout	9.44e-05	0.0026	CbGpPWpGaD
Nilotinib—Dry skin—Prednisone—gout	9.43e-05	0.000535	CcSEcCtD
Nilotinib—Headache—Allopurinol—gout	9.41e-05	0.000533	CcSEcCtD
Nilotinib—Asthenia—Naproxen—gout	9.41e-05	0.000533	CcSEcCtD
Nilotinib—Connective tissue disorder—Hydrocortisone—gout	9.4e-05	0.000533	CcSEcCtD
Nilotinib—Hypokalaemia—Prednisone—gout	9.37e-05	0.000531	CcSEcCtD
Nilotinib—KIT—Disease—PRPS1—gout	9.32e-05	0.00256	CbGpPWpGaD
Nilotinib—KIT—Disease—PRPS2—gout	9.32e-05	0.00256	CbGpPWpGaD
Nilotinib—BLK—Immune System—NLRP3—gout	9.3e-05	0.00256	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—NLRP3—gout	9.3e-05	0.00256	CbGpPWpGaD
Nilotinib—Pruritus—Naproxen—gout	9.27e-05	0.000526	CcSEcCtD
Nilotinib—FGR—Immune System—NLRP3—gout	9.27e-05	0.00255	CbGpPWpGaD
Nilotinib—Bradycardia—Methylprednisolone—gout	9.15e-05	0.000519	CcSEcCtD
Nilotinib—MAPK14—Innate Immune System—NLRP3—gout	9.08e-05	0.0025	CbGpPWpGaD
Nilotinib—Muscular weakness—Prednisone—gout	9.08e-05	0.000514	CcSEcCtD
Nilotinib—Alanine aminotransferase increased—Prednisone—gout	9.08e-05	0.000514	CcSEcCtD
Nilotinib—Haemoglobin—Methylprednisolone—gout	9.04e-05	0.000512	CcSEcCtD
Nilotinib—Rhinitis—Methylprednisolone—gout	9.01e-05	0.000511	CcSEcCtD
Nilotinib—Haemorrhage—Methylprednisolone—gout	8.99e-05	0.000509	CcSEcCtD
Nilotinib—Diarrhoea—Naproxen—gout	8.97e-05	0.000508	CcSEcCtD
Nilotinib—Abdominal distension—Prednisone—gout	8.96e-05	0.000507	CcSEcCtD
Nilotinib—Eye disorder—Hydrocortisone—gout	8.94e-05	0.000507	CcSEcCtD
Nilotinib—Nausea—Allopurinol—gout	8.92e-05	0.000505	CcSEcCtD
Nilotinib—Connective tissue disorder—Methylprednisolone—gout	8.84e-05	0.000501	CcSEcCtD
Nilotinib—PDGFRA—Disease—PRPS1—gout	8.82e-05	0.00242	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—PRPS2—gout	8.82e-05	0.00242	CbGpPWpGaD
Nilotinib—CA2—tendon—gout	8.76e-05	0.0172	CbGeAlD
Nilotinib—Arrhythmia—Prednisolone—gout	8.75e-05	0.000496	CcSEcCtD
Nilotinib—Pancreatitis—Prednisone—gout	8.72e-05	0.000494	CcSEcCtD
Nilotinib—Dizziness—Naproxen—gout	8.67e-05	0.000491	CcSEcCtD
Nilotinib—Visual impairment—Methylprednisolone—gout	8.66e-05	0.000491	CcSEcCtD
Nilotinib—Immune system disorder—Hydrocortisone—gout	8.64e-05	0.00049	CcSEcCtD
Nilotinib—HCK—Innate Immune System—CASP1—gout	8.61e-05	0.00237	CbGpPWpGaD
Nilotinib—Arrhythmia—Hydrocortisone—gout	8.55e-05	0.000484	CcSEcCtD
Nilotinib—Erythema—Prednisolone—gout	8.53e-05	0.000483	CcSEcCtD
Nilotinib—Eye disorder—Methylprednisolone—gout	8.4e-05	0.000476	CcSEcCtD
Nilotinib—Mental disorder—Hydrocortisone—gout	8.38e-05	0.000475	CcSEcCtD
Nilotinib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	8.37e-05	0.0023	CbGpPWpGaD
Nilotinib—LYN—Cytokine Signaling in Immune system—CASP1—gout	8.35e-05	0.00229	CbGpPWpGaD
Nilotinib—Cardiac disorder—Methylprednisolone—gout	8.34e-05	0.000473	CcSEcCtD
Nilotinib—Vomiting—Naproxen—gout	8.33e-05	0.000472	CcSEcCtD
Nilotinib—Malnutrition—Hydrocortisone—gout	8.33e-05	0.000472	CcSEcCtD
Nilotinib—Erythema—Hydrocortisone—gout	8.33e-05	0.000472	CcSEcCtD
Nilotinib—Neutropenia—Prednisone—gout	8.32e-05	0.000471	CcSEcCtD
Nilotinib—Rash—Naproxen—gout	8.27e-05	0.000468	CcSEcCtD
Nilotinib—Dermatitis—Naproxen—gout	8.26e-05	0.000468	CcSEcCtD
Nilotinib—Headache—Naproxen—gout	8.21e-05	0.000465	CcSEcCtD
Nilotinib—Erectile dysfunction—Prednisone—gout	8.19e-05	0.000464	CcSEcCtD
Nilotinib—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—gout	8.16e-05	0.00224	CbGpPWpGaD
Nilotinib—Angiopathy—Methylprednisolone—gout	8.16e-05	0.000462	CcSEcCtD
Nilotinib—Immune system disorder—Methylprednisolone—gout	8.12e-05	0.00046	CcSEcCtD
Nilotinib—Mediastinal disorder—Methylprednisolone—gout	8.1e-05	0.000459	CcSEcCtD
Nilotinib—Weight increased—Prednisone—gout	8.1e-05	0.000459	CcSEcCtD
Nilotinib—LYN—Cytokine Signaling in Immune system—IL1RN—gout	8.08e-05	0.00222	CbGpPWpGaD
Nilotinib—Weight decreased—Prednisone—gout	8.05e-05	0.000456	CcSEcCtD
Nilotinib—Vision blurred—Prednisolone—gout	8.04e-05	0.000455	CcSEcCtD
Nilotinib—Arrhythmia—Methylprednisolone—gout	8.03e-05	0.000455	CcSEcCtD
Nilotinib—Hyperglycaemia—Prednisone—gout	8.02e-05	0.000455	CcSEcCtD
Nilotinib—PDGFRB—Disease—PRPS2—gout	7.95e-05	0.00218	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—PRPS1—gout	7.95e-05	0.00218	CbGpPWpGaD
Nilotinib—Ill-defined disorder—Prednisolone—gout	7.91e-05	0.000448	CcSEcCtD
Nilotinib—Mental disorder—Methylprednisolone—gout	7.88e-05	0.000446	CcSEcCtD
Nilotinib—LCK—Innate Immune System—NLRP3—gout	7.85e-05	0.00216	CbGpPWpGaD
Nilotinib—Erythema—Methylprednisolone—gout	7.83e-05	0.000443	CcSEcCtD
Nilotinib—Malnutrition—Methylprednisolone—gout	7.83e-05	0.000443	CcSEcCtD
Nilotinib—Acute coronary syndrome—Prednisone—gout	7.82e-05	0.000443	CcSEcCtD
Nilotinib—MAPK8—Innate Immune System—CASP1—gout	7.8e-05	0.00214	CbGpPWpGaD
Nilotinib—Nausea—Naproxen—gout	7.79e-05	0.000441	CcSEcCtD
Nilotinib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	7.78e-05	0.00214	CbGpPWpGaD
Nilotinib—FGR—Innate Immune System—CASP1—gout	7.78e-05	0.00214	CbGpPWpGaD
Nilotinib—Neuropathy peripheral—Prednisone—gout	7.77e-05	0.000441	CcSEcCtD
Nilotinib—Myocardial infarction—Prednisone—gout	7.77e-05	0.000441	CcSEcCtD
Nilotinib—Ill-defined disorder—Hydrocortisone—gout	7.73e-05	0.000438	CcSEcCtD
Nilotinib—Malaise—Prednisolone—gout	7.69e-05	0.000436	CcSEcCtD
Nilotinib—Vertigo—Prednisolone—gout	7.66e-05	0.000434	CcSEcCtD
Nilotinib—Syncope—Prednisolone—gout	7.65e-05	0.000433	CcSEcCtD
Nilotinib—Malaise—Hydrocortisone—gout	7.51e-05	0.000426	CcSEcCtD
Nilotinib—Loss of consciousness—Prednisolone—gout	7.5e-05	0.000425	CcSEcCtD
Nilotinib—Vertigo—Hydrocortisone—gout	7.48e-05	0.000424	CcSEcCtD
Nilotinib—UGT1A1—Metabolism—BCKDHA—gout	7.48e-05	0.00206	CbGpPWpGaD
Nilotinib—Syncope—Hydrocortisone—gout	7.47e-05	0.000423	CcSEcCtD
Nilotinib—MAPK11—Immune System—NLRP3—gout	7.41e-05	0.00204	CbGpPWpGaD
Nilotinib—Hypertension—Prednisolone—gout	7.36e-05	0.000417	CcSEcCtD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	7.33e-05	0.00201	CbGpPWpGaD
Nilotinib—Loss of consciousness—Hydrocortisone—gout	7.32e-05	0.000415	CcSEcCtD
Nilotinib—Ill-defined disorder—Methylprednisolone—gout	7.26e-05	0.000411	CcSEcCtD
Nilotinib—Bradycardia—Prednisone—gout	7.25e-05	0.000411	CcSEcCtD
Nilotinib—Hypertension—Hydrocortisone—gout	7.19e-05	0.000408	CcSEcCtD
Nilotinib—Discomfort—Prednisolone—gout	7.17e-05	0.000407	CcSEcCtD
Nilotinib—Haemoglobin—Prednisone—gout	7.16e-05	0.000405	CcSEcCtD
Nilotinib—Haemorrhage—Prednisone—gout	7.12e-05	0.000403	CcSEcCtD
Nilotinib—Myalgia—Hydrocortisone—gout	7.09e-05	0.000402	CcSEcCtD
Nilotinib—Anxiety—Hydrocortisone—gout	7.07e-05	0.0004	CcSEcCtD
Nilotinib—Malaise—Methylprednisolone—gout	7.06e-05	0.0004	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	7.04e-05	0.000399	CcSEcCtD
Nilotinib—Vertigo—Methylprednisolone—gout	7.03e-05	0.000398	CcSEcCtD
Nilotinib—Syncope—Methylprednisolone—gout	7.02e-05	0.000398	CcSEcCtD
Nilotinib—Discomfort—Hydrocortisone—gout	7.01e-05	0.000397	CcSEcCtD
Nilotinib—Connective tissue disorder—Prednisone—gout	7e-05	0.000396	CcSEcCtD
Nilotinib—CA14—Metabolism—ABCG2—gout	6.98e-05	0.00192	CbGpPWpGaD
Nilotinib—Oedema—Prednisolone—gout	6.96e-05	0.000394	CcSEcCtD
Nilotinib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	6.91e-05	0.0019	CbGpPWpGaD
Nilotinib—Loss of consciousness—Methylprednisolone—gout	6.88e-05	0.00039	CcSEcCtD
Nilotinib—Shock—Prednisolone—gout	6.85e-05	0.000388	CcSEcCtD
Nilotinib—LCK—Cytokine Signaling in Immune system—CASP1—gout	6.84e-05	0.00188	CbGpPWpGaD
Nilotinib—Oedema—Hydrocortisone—gout	6.8e-05	0.000385	CcSEcCtD
Nilotinib—CA6—Metabolism—ABCG2—gout	6.8e-05	0.00187	CbGpPWpGaD
Nilotinib—Tachycardia—Prednisolone—gout	6.79e-05	0.000385	CcSEcCtD
Nilotinib—Hypertension—Methylprednisolone—gout	6.76e-05	0.000383	CcSEcCtD
Nilotinib—Infection—Hydrocortisone—gout	6.75e-05	0.000383	CcSEcCtD
Nilotinib—Hyperhidrosis—Prednisolone—gout	6.73e-05	0.000381	CcSEcCtD
Nilotinib—Shock—Hydrocortisone—gout	6.69e-05	0.000379	CcSEcCtD
Nilotinib—KIT—Immune System—NLRP3—gout	6.68e-05	0.00184	CbGpPWpGaD
Nilotinib—Nervous system disorder—Hydrocortisone—gout	6.67e-05	0.000378	CcSEcCtD
Nilotinib—Myalgia—Methylprednisolone—gout	6.66e-05	0.000378	CcSEcCtD
Nilotinib—Arthralgia—Methylprednisolone—gout	6.66e-05	0.000378	CcSEcCtD
Nilotinib—Eye disorder—Prednisone—gout	6.65e-05	0.000377	CcSEcCtD
Nilotinib—Anxiety—Methylprednisolone—gout	6.64e-05	0.000376	CcSEcCtD
Nilotinib—Tachycardia—Hydrocortisone—gout	6.64e-05	0.000376	CcSEcCtD
Nilotinib—LCK—Cytokine Signaling in Immune system—IL1RN—gout	6.62e-05	0.00182	CbGpPWpGaD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	6.62e-05	0.000375	CcSEcCtD
Nilotinib—CYP2B6—Phase 1 - Functionalization of compounds—POMC—gout	6.62e-05	0.00182	CbGpPWpGaD
Nilotinib—Flushing—Prednisone—gout	6.61e-05	0.000374	CcSEcCtD
Nilotinib—Skin disorder—Hydrocortisone—gout	6.6e-05	0.000374	CcSEcCtD
Nilotinib—Discomfort—Methylprednisolone—gout	6.58e-05	0.000373	CcSEcCtD
Nilotinib—Hyperhidrosis—Hydrocortisone—gout	6.57e-05	0.000372	CcSEcCtD
Nilotinib—Anorexia—Hydrocortisone—gout	6.48e-05	0.000367	CcSEcCtD
Nilotinib—Angiopathy—Prednisone—gout	6.46e-05	0.000366	CcSEcCtD
Nilotinib—Confusional state—Methylprednisolone—gout	6.44e-05	0.000365	CcSEcCtD
Nilotinib—Immune system disorder—Prednisone—gout	6.43e-05	0.000364	CcSEcCtD
Nilotinib—LCK—Disease—PRPS2—gout	6.38e-05	0.00175	CbGpPWpGaD
Nilotinib—LCK—Disease—PRPS1—gout	6.38e-05	0.00175	CbGpPWpGaD
Nilotinib—Arrhythmia—Prednisone—gout	6.36e-05	0.00036	CcSEcCtD
Nilotinib—Hypotension—Hydrocortisone—gout	6.35e-05	0.00036	CcSEcCtD
Nilotinib—Infection—Methylprednisolone—gout	6.35e-05	0.00036	CcSEcCtD
Nilotinib—ABCG2—Metabolism—BCKDHA—gout	6.35e-05	0.00174	CbGpPWpGaD
Nilotinib—CA7—Metabolism—ABCG2—gout	6.35e-05	0.00174	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—NLRP3—gout	6.33e-05	0.00174	CbGpPWpGaD
Nilotinib—Insomnia—Prednisolone—gout	6.3e-05	0.000357	CcSEcCtD
Nilotinib—Alopecia—Prednisone—gout	6.29e-05	0.000357	CcSEcCtD
Nilotinib—Shock—Methylprednisolone—gout	6.28e-05	0.000356	CcSEcCtD
Nilotinib—Nervous system disorder—Methylprednisolone—gout	6.26e-05	0.000355	CcSEcCtD
Nilotinib—Paraesthesia—Prednisolone—gout	6.25e-05	0.000354	CcSEcCtD
Nilotinib—Mental disorder—Prednisone—gout	6.24e-05	0.000353	CcSEcCtD
Nilotinib—Tachycardia—Methylprednisolone—gout	6.23e-05	0.000353	CcSEcCtD
Nilotinib—MAPK11—Innate Immune System—CASP1—gout	6.22e-05	0.00171	CbGpPWpGaD
Nilotinib—Skin disorder—Methylprednisolone—gout	6.2e-05	0.000352	CcSEcCtD
Nilotinib—Malnutrition—Prednisone—gout	6.2e-05	0.000351	CcSEcCtD
Nilotinib—Erythema—Prednisone—gout	6.2e-05	0.000351	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Hydrocortisone—gout	6.19e-05	0.000351	CcSEcCtD
Nilotinib—Hyperhidrosis—Methylprednisolone—gout	6.18e-05	0.00035	CcSEcCtD
Nilotinib—Insomnia—Hydrocortisone—gout	6.15e-05	0.000348	CcSEcCtD
Nilotinib—Paraesthesia—Hydrocortisone—gout	6.11e-05	0.000346	CcSEcCtD
Nilotinib—UGT1A1—Metabolism—HPRT1—gout	6.1e-05	0.00168	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PRPS2—gout	6.1e-05	0.00168	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—PRPS1—gout	6.1e-05	0.00168	CbGpPWpGaD
Nilotinib—Dyspepsia—Hydrocortisone—gout	5.98e-05	0.000339	CcSEcCtD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	5.97e-05	0.00164	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	5.97e-05	0.00164	CbGpPWpGaD
Nilotinib—Hypotension—Methylprednisolone—gout	5.97e-05	0.000338	CcSEcCtD
Nilotinib—Pain—Prednisolone—gout	5.95e-05	0.000337	CcSEcCtD
Nilotinib—Decreased appetite—Hydrocortisone—gout	5.91e-05	0.000335	CcSEcCtD
Nilotinib—CA12—Metabolism—ABCG2—gout	5.88e-05	0.00162	CbGpPWpGaD
Nilotinib—Gastrointestinal disorder—Hydrocortisone—gout	5.87e-05	0.000333	CcSEcCtD
Nilotinib—Fatigue—Hydrocortisone—gout	5.86e-05	0.000332	CcSEcCtD
Nilotinib—Vision blurred—Prednisone—gout	5.84e-05	0.000331	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Methylprednisolone—gout	5.82e-05	0.00033	CcSEcCtD
Nilotinib—Pain—Hydrocortisone—gout	5.81e-05	0.000329	CcSEcCtD
Nilotinib—Insomnia—Methylprednisolone—gout	5.78e-05	0.000327	CcSEcCtD
Nilotinib—Ill-defined disorder—Prednisone—gout	5.75e-05	0.000326	CcSEcCtD
Nilotinib—Feeling abnormal—Prednisolone—gout	5.74e-05	0.000325	CcSEcCtD
Nilotinib—Paraesthesia—Methylprednisolone—gout	5.74e-05	0.000325	CcSEcCtD
Nilotinib—Anaemia—Prednisone—gout	5.73e-05	0.000325	CcSEcCtD
Nilotinib—PDGFRB—Immune System—NLRP3—gout	5.7e-05	0.00157	CbGpPWpGaD
Nilotinib—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—gout	5.67e-05	0.00156	CbGpPWpGaD
Nilotinib—UGT1A1—Biological oxidations—POMC—gout	5.65e-05	0.00155	CbGpPWpGaD
Nilotinib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	5.62e-05	0.00155	CbGpPWpGaD
Nilotinib—Dyspepsia—Methylprednisolone—gout	5.62e-05	0.000319	CcSEcCtD
Nilotinib—KIT—Innate Immune System—CASP1—gout	5.61e-05	0.00154	CbGpPWpGaD
Nilotinib—Feeling abnormal—Hydrocortisone—gout	5.6e-05	0.000317	CcSEcCtD
Nilotinib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	5.6e-05	0.00154	CbGpPWpGaD
Nilotinib—Malaise—Prednisone—gout	5.59e-05	0.000317	CcSEcCtD
Nilotinib—LYN—Immune System—NLRP3—gout	5.58e-05	0.00153	CbGpPWpGaD
Nilotinib—Vertigo—Prednisone—gout	5.57e-05	0.000316	CcSEcCtD
Nilotinib—Gastrointestinal pain—Hydrocortisone—gout	5.56e-05	0.000315	CcSEcCtD
Nilotinib—Syncope—Prednisone—gout	5.56e-05	0.000315	CcSEcCtD
Nilotinib—ABL1—Immune System—NLRP3—gout	5.56e-05	0.00153	CbGpPWpGaD
Nilotinib—Urticaria—Prednisolone—gout	5.53e-05	0.000313	CcSEcCtD
Nilotinib—Fatigue—Methylprednisolone—gout	5.51e-05	0.000312	CcSEcCtD
Nilotinib—Loss of consciousness—Prednisone—gout	5.45e-05	0.000309	CcSEcCtD
Nilotinib—Urticaria—Hydrocortisone—gout	5.4e-05	0.000306	CcSEcCtD
Nilotinib—Abdominal pain—Hydrocortisone—gout	5.37e-05	0.000305	CcSEcCtD
Nilotinib—Body temperature increased—Hydrocortisone—gout	5.37e-05	0.000305	CcSEcCtD
Nilotinib—Hypertension—Prednisone—gout	5.35e-05	0.000303	CcSEcCtD
Nilotinib—PDGFRA—Innate Immune System—CASP1—gout	5.31e-05	0.00146	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—NLRP3—gout	5.29e-05	0.00145	CbGpPWpGaD
Nilotinib—Myalgia—Prednisone—gout	5.28e-05	0.000299	CcSEcCtD
Nilotinib—Arthralgia—Prednisone—gout	5.28e-05	0.000299	CcSEcCtD
Nilotinib—Feeling abnormal—Methylprednisolone—gout	5.26e-05	0.000298	CcSEcCtD
Nilotinib—Anxiety—Prednisone—gout	5.26e-05	0.000298	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	5.24e-05	0.000297	CcSEcCtD
Nilotinib—Gastrointestinal pain—Methylprednisolone—gout	5.22e-05	0.000296	CcSEcCtD
Nilotinib—Discomfort—Prednisone—gout	5.21e-05	0.000295	CcSEcCtD
Nilotinib—ABCG2—Metabolism—PRPS2—gout	5.17e-05	0.00142	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—HPRT1—gout	5.17e-05	0.00142	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PRPS1—gout	5.17e-05	0.00142	CbGpPWpGaD
Nilotinib—Hypersensitivity—Prednisolone—gout	5.13e-05	0.000291	CcSEcCtD
Nilotinib—Urticaria—Methylprednisolone—gout	5.07e-05	0.000288	CcSEcCtD
Nilotinib—Oedema—Prednisone—gout	5.06e-05	0.000287	CcSEcCtD
Nilotinib—Abdominal pain—Methylprednisolone—gout	5.05e-05	0.000286	CcSEcCtD
Nilotinib—Infection—Prednisone—gout	5.03e-05	0.000285	CcSEcCtD
Nilotinib—HCK—Immune System—CASP1—gout	5.01e-05	0.00138	CbGpPWpGaD
Nilotinib—Hypersensitivity—Hydrocortisone—gout	5.01e-05	0.000284	CcSEcCtD
Nilotinib—Shock—Prednisone—gout	4.98e-05	0.000282	CcSEcCtD
Nilotinib—Nervous system disorder—Prednisone—gout	4.96e-05	0.000281	CcSEcCtD
Nilotinib—Tachycardia—Prednisone—gout	4.94e-05	0.00028	CcSEcCtD
Nilotinib—Skin disorder—Prednisone—gout	4.91e-05	0.000278	CcSEcCtD
Nilotinib—Hyperhidrosis—Prednisone—gout	4.89e-05	0.000277	CcSEcCtD
Nilotinib—Asthenia—Hydrocortisone—gout	4.88e-05	0.000276	CcSEcCtD
Nilotinib—HCK—Immune System—IL1RN—gout	4.86e-05	0.00134	CbGpPWpGaD
Nilotinib—Anorexia—Prednisone—gout	4.82e-05	0.000273	CcSEcCtD
Nilotinib—Pruritus—Hydrocortisone—gout	4.81e-05	0.000273	CcSEcCtD
Nilotinib—PDGFRB—Innate Immune System—CASP1—gout	4.78e-05	0.00131	CbGpPWpGaD
Nilotinib—Hypersensitivity—Methylprednisolone—gout	4.71e-05	0.000267	CcSEcCtD
Nilotinib—CA4—Metabolism—ABCG2—gout	4.69e-05	0.00129	CbGpPWpGaD
Nilotinib—LYN—Innate Immune System—CASP1—gout	4.68e-05	0.00129	CbGpPWpGaD
Nilotinib—ABL1—Innate Immune System—CASP1—gout	4.66e-05	0.00128	CbGpPWpGaD
Nilotinib—Diarrhoea—Hydrocortisone—gout	4.65e-05	0.000264	CcSEcCtD
Nilotinib—CYP2B6—Metabolism—BCKDHA—gout	4.65e-05	0.00128	CbGpPWpGaD
Nilotinib—CA3—Metabolism—POMC—gout	4.64e-05	0.00127	CbGpPWpGaD
Nilotinib—Musculoskeletal discomfort—Prednisone—gout	4.61e-05	0.000261	CcSEcCtD
Nilotinib—Dizziness—Prednisolone—gout	4.6e-05	0.000261	CcSEcCtD
Nilotinib—CYP2D6—Phase 1 - Functionalization of compounds—POMC—gout	4.6e-05	0.00126	CbGpPWpGaD
Nilotinib—Asthenia—Methylprednisolone—gout	4.58e-05	0.00026	CcSEcCtD
Nilotinib—Insomnia—Prednisone—gout	4.58e-05	0.000259	CcSEcCtD
Nilotinib—LCK—Immune System—NLRP3—gout	4.57e-05	0.00126	CbGpPWpGaD
Nilotinib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	4.56e-05	0.00125	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—CASP1—gout	4.54e-05	0.00125	CbGpPWpGaD
Nilotinib—BLK—Immune System—CASP1—gout	4.54e-05	0.00125	CbGpPWpGaD
Nilotinib—Paraesthesia—Prednisone—gout	4.54e-05	0.000257	CcSEcCtD
Nilotinib—FGR—Immune System—CASP1—gout	4.53e-05	0.00125	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	4.53e-05	0.00124	CbGpPWpGaD
Nilotinib—Pruritus—Methylprednisolone—gout	4.52e-05	0.000256	CcSEcCtD
Nilotinib—Dizziness—Hydrocortisone—gout	4.5e-05	0.000255	CcSEcCtD
Nilotinib—CA2—Metabolism—ABCG2—gout	4.49e-05	0.00124	CbGpPWpGaD
Nilotinib—Dyspepsia—Prednisone—gout	4.45e-05	0.000252	CcSEcCtD
Nilotinib—MAPK14—Innate Immune System—CASP1—gout	4.44e-05	0.00122	CbGpPWpGaD
Nilotinib—BLK—Immune System—IL1RN—gout	4.4e-05	0.00121	CbGpPWpGaD
Nilotinib—MAPK8—Immune System—IL1RN—gout	4.4e-05	0.00121	CbGpPWpGaD
Nilotinib—Decreased appetite—Prednisone—gout	4.4e-05	0.000249	CcSEcCtD
Nilotinib—Rash—Prednisolone—gout	4.39e-05	0.000249	CcSEcCtD
Nilotinib—FGR—Immune System—IL1RN—gout	4.39e-05	0.00121	CbGpPWpGaD
Nilotinib—Dermatitis—Prednisolone—gout	4.39e-05	0.000248	CcSEcCtD
Nilotinib—Diarrhoea—Methylprednisolone—gout	4.37e-05	0.000248	CcSEcCtD
Nilotinib—Fatigue—Prednisone—gout	4.36e-05	0.000247	CcSEcCtD
Nilotinib—Headache—Prednisolone—gout	4.36e-05	0.000247	CcSEcCtD
Nilotinib—Constipation—Prednisone—gout	4.33e-05	0.000245	CcSEcCtD
Nilotinib—Vomiting—Hydrocortisone—gout	4.32e-05	0.000245	CcSEcCtD
Nilotinib—CA1—Metabolism—ABCG2—gout	4.31e-05	0.00118	CbGpPWpGaD
Nilotinib—Rash—Hydrocortisone—gout	4.29e-05	0.000243	CcSEcCtD
Nilotinib—Dermatitis—Hydrocortisone—gout	4.28e-05	0.000243	CcSEcCtD
Nilotinib—Headache—Hydrocortisone—gout	4.26e-05	0.000241	CcSEcCtD
Nilotinib—Dizziness—Methylprednisolone—gout	4.22e-05	0.000239	CcSEcCtD
Nilotinib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	4.21e-05	0.00116	CbGpPWpGaD
Nilotinib—Feeling abnormal—Prednisone—gout	4.17e-05	0.000236	CcSEcCtD
Nilotinib—Gastrointestinal pain—Prednisone—gout	4.14e-05	0.000234	CcSEcCtD
Nilotinib—Nausea—Prednisolone—gout	4.14e-05	0.000234	CcSEcCtD
Nilotinib—Vomiting—Methylprednisolone—gout	4.06e-05	0.00023	CcSEcCtD
Nilotinib—Nausea—Hydrocortisone—gout	4.04e-05	0.000229	CcSEcCtD
Nilotinib—Rash—Methylprednisolone—gout	4.03e-05	0.000228	CcSEcCtD
Nilotinib—Dermatitis—Methylprednisolone—gout	4.02e-05	0.000228	CcSEcCtD
Nilotinib—Urticaria—Prednisone—gout	4.02e-05	0.000228	CcSEcCtD
Nilotinib—Headache—Methylprednisolone—gout	4e-05	0.000227	CcSEcCtD
Nilotinib—Abdominal pain—Prednisone—gout	4e-05	0.000227	CcSEcCtD
Nilotinib—Body temperature increased—Prednisone—gout	4e-05	0.000227	CcSEcCtD
Nilotinib—CYP2C8—Metabolism—BCKDHA—gout	3.94e-05	0.00108	CbGpPWpGaD
Nilotinib—LCK—Innate Immune System—CASP1—gout	3.84e-05	0.00105	CbGpPWpGaD
Nilotinib—Nausea—Methylprednisolone—gout	3.79e-05	0.000215	CcSEcCtD
Nilotinib—CYP2B6—Metabolism—PRPS2—gout	3.79e-05	0.00104	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—HPRT1—gout	3.79e-05	0.00104	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PRPS1—gout	3.79e-05	0.00104	CbGpPWpGaD
Nilotinib—CA9—Metabolism—ABCG2—gout	3.79e-05	0.00104	CbGpPWpGaD
Nilotinib—Hypersensitivity—Prednisone—gout	3.73e-05	0.000211	CcSEcCtD
Nilotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	3.71e-05	0.00102	CbGpPWpGaD
Nilotinib—Asthenia—Prednisone—gout	3.63e-05	0.000206	CcSEcCtD
Nilotinib—MAPK11—Immune System—CASP1—gout	3.62e-05	0.000995	CbGpPWpGaD
Nilotinib—Pruritus—Prednisone—gout	3.58e-05	0.000203	CcSEcCtD
Nilotinib—CYP2B6—Biological oxidations—POMC—gout	3.51e-05	0.000966	CbGpPWpGaD
Nilotinib—MAPK11—Immune System—IL1RN—gout	3.51e-05	0.000964	CbGpPWpGaD
Nilotinib—Diarrhoea—Prednisone—gout	3.46e-05	0.000196	CcSEcCtD
Nilotinib—ABCB1—Metabolism—BCKDHA—gout	3.43e-05	0.000943	CbGpPWpGaD
Nilotinib—Dizziness—Prednisone—gout	3.35e-05	0.00019	CcSEcCtD
Nilotinib—KIT—Immune System—CASP1—gout	3.26e-05	0.000898	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—BCKDHA—gout	3.23e-05	0.000889	CbGpPWpGaD
Nilotinib—Vomiting—Prednisone—gout	3.22e-05	0.000182	CcSEcCtD
Nilotinib—CYP2C8—Metabolism—HPRT1—gout	3.21e-05	0.000883	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PRPS1—gout	3.21e-05	0.000883	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PRPS2—gout	3.21e-05	0.000883	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—BCKDHA—gout	3.21e-05	0.000881	CbGpPWpGaD
Nilotinib—Rash—Prednisone—gout	3.19e-05	0.000181	CcSEcCtD
Nilotinib—Dermatitis—Prednisone—gout	3.19e-05	0.000181	CcSEcCtD
Nilotinib—Headache—Prednisone—gout	3.17e-05	0.00018	CcSEcCtD
Nilotinib—KIT—Immune System—IL1RN—gout	3.16e-05	0.000869	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—CASP1—gout	3.09e-05	0.00085	CbGpPWpGaD
Nilotinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	3.01e-05	0.000827	CbGpPWpGaD
Nilotinib—Nausea—Prednisone—gout	3e-05	0.00017	CcSEcCtD
Nilotinib—PDGFRA—Immune System—IL1RN—gout	2.99e-05	0.000823	CbGpPWpGaD
Nilotinib—CA14—Metabolism—POMC—gout	2.99e-05	0.000821	CbGpPWpGaD
Nilotinib—CYP2C8—Biological oxidations—POMC—gout	2.98e-05	0.000818	CbGpPWpGaD
Nilotinib—CA6—Metabolism—POMC—gout	2.91e-05	0.0008	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PRPS2—gout	2.8e-05	0.000769	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—HPRT1—gout	2.8e-05	0.000769	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PRPS1—gout	2.8e-05	0.000769	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—CASP1—gout	2.78e-05	0.000765	CbGpPWpGaD
Nilotinib—LYN—Immune System—CASP1—gout	2.73e-05	0.000749	CbGpPWpGaD
Nilotinib—CA7—Metabolism—POMC—gout	2.72e-05	0.000747	CbGpPWpGaD
Nilotinib—ABL1—Immune System—CASP1—gout	2.71e-05	0.000746	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL1RN—gout	2.7e-05	0.000741	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL1RN—gout	2.64e-05	0.000726	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—HPRT1—gout	2.64e-05	0.000725	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PRPS2—gout	2.64e-05	0.000725	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PRPS1—gout	2.64e-05	0.000725	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL1RN—gout	2.63e-05	0.000722	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PRPS1—gout	2.61e-05	0.000718	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—HPRT1—gout	2.61e-05	0.000718	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PRPS2—gout	2.61e-05	0.000718	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—CASP1—gout	2.58e-05	0.00071	CbGpPWpGaD
Nilotinib—CA12—Metabolism—POMC—gout	2.52e-05	0.000692	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL1RN—gout	2.5e-05	0.000688	CbGpPWpGaD
Nilotinib—CYP2D6—Biological oxidations—POMC—gout	2.44e-05	0.000672	CbGpPWpGaD
Nilotinib—CYP2C9—Biological oxidations—POMC—gout	2.42e-05	0.000666	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—ABCG2—gout	2.26e-05	0.00062	CbGpPWpGaD
Nilotinib—LCK—Immune System—CASP1—gout	2.23e-05	0.000614	CbGpPWpGaD
Nilotinib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	2.21e-05	0.000608	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL1RN—gout	2.16e-05	0.000595	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—BCKDHA—gout	2.11e-05	0.000581	CbGpPWpGaD
Nilotinib—CA4—Metabolism—POMC—gout	2.01e-05	0.000552	CbGpPWpGaD
Nilotinib—CA2—Metabolism—POMC—gout	1.92e-05	0.000529	CbGpPWpGaD
Nilotinib—CA1—Metabolism—POMC—gout	1.85e-05	0.000507	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HPRT1—gout	1.72e-05	0.000474	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PRPS2—gout	1.72e-05	0.000474	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PRPS1—gout	1.72e-05	0.000474	CbGpPWpGaD
Nilotinib—CA9—Metabolism—POMC—gout	1.62e-05	0.000446	CbGpPWpGaD
Nilotinib—CYP3A4—Biological oxidations—POMC—gout	1.6e-05	0.000439	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—POMC—gout	1.44e-05	0.000396	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ABCG2—gout	1.4e-05	0.000386	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—POMC—gout	1.37e-05	0.000376	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ABCG2—gout	1.19e-05	0.000327	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—POMC—gout	1.15e-05	0.000315	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	1.14e-05	0.000314	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—POMC—gout	1.14e-05	0.000312	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ABCG2—gout	1.04e-05	0.000285	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—POMC—gout	1.03e-05	0.000284	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—POMC—gout	9.79e-06	0.000269	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ABCG2—gout	9.75e-06	0.000268	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ABCG2—gout	9.67e-06	0.000266	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—POMC—gout	9.66e-06	0.000266	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	9.3e-06	0.000256	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—POMC—gout	8.82e-06	0.000242	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—POMC—gout	8.63e-06	0.000237	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—POMC—gout	8.2e-06	0.000225	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—POMC—gout	8.18e-06	0.000225	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—POMC—gout	7.08e-06	0.000195	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ABCG2—gout	6.38e-06	0.000175	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—gout	6.01e-06	0.000165	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—gout	5.09e-06	0.00014	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—gout	4.43e-06	0.000122	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—gout	4.18e-06	0.000115	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—gout	4.14e-06	0.000114	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—gout	2.73e-06	7.51e-05	CbGpPWpGaD
